Alka Chaubey Bionano Genomics, Inc. (BNGO) insider trading activity

Alka Chaubey is Chief Medical Officer of Bionano Genomics, Inc.. Currently has a direct ownership of 662 shares of BNGO, which is worth approximately $1,290. The most recent transaction as insider was on Sep 11, 2025, when has been sold 51 shares (Common Stock) at a price of $4.06 per share, resulting in proceeds of $207. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 662

7.15% 3M change

98.54% 12M change

Total Value Held $1,290

Alka Chaubey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2025	SELL Payment of exercise price or tax liability	$207 $4.06 p/Share	51 Reduced 7.15%	662 Common Stock
Jun 03 2025	SELL Payment of exercise price or tax liability	$88 $3.69 p/Share	24 Reduced 3.26%	713 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$103 $5.73 p/Share	18 Reduced 2.38%	737 Common Stock
Sep 11 2024	SELL Payment of exercise price or tax liability	$1,476 $0.48 p/Share	3,075 Reduced 6.35%	45,323 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	16,000 Added 24.9%	48,245 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$1,372 $1.27 p/Share	1,081 Reduced 3.32%	31,487 Common Stock
Sep 18 2023	BUY Grant, award, or other acquisition	-	20,000 Added 12.14%	144,794 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	-	120,000 Added 49.02%	124,794 Common Stock

Alka Chaubey

Chief Medical Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNGO shares.

Notify only if

Value

Insider Trading

Get notified when an Bionano Genomics, Inc. insider buys or sells BNGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Bionano Genomics, Inc.

Track Activities on BNGO

Account